Failure-to-success ratios, transition probabilities and phase lengths for prophylactic vaccines versus other pharmaceuticals in the development pipeline
Matthew M. Davis, Amy T. Butchart, John R.C. Wheeler, Margaret S. Coleman, Dianne C. Singer, Gary L. FreedVolume:
29
Year:
2011
Language:
english
DOI:
10.1016/j.vaccine.2011.09.128
File:
PDF, 188 KB
english, 2011